12 biological applications of these structures remain unexplored. Here we describe the use of 13 DNA to control the biological delivery and elimination of inorganic nanoparticles by 14 organizing them into colloidal superstructures. The individual nanoparticles serve as 15 building blocks, whose size, surface chemistry, and assembly architecture dictate overall 16 superstructure design. These superstructures interact with cells and tissues as a function 17 of their design, but subsequently degrade into building blocks that can escape biological 18 sequestration. We demonstrate that this strategy reduces nanoparticle retention by 19 macrophages, and improves their in vivo tumour accumulation and whole-body 20 elimination. Superstructures can be further functionalized to carry and protect imaging or 21 therapeutic agents against enzymatic degradation. These results suggest a new strategy to 22 engineer nanostructure interactions with biological systems, and highlight new directions 23 in the design of biodegradable and multifunctional nanomedicine.
illustrates the principles of using DNA-nanoparticle assembly to engineer colloidal 48 superstructures with different physicochemical properties. First, we used metal-thiol or 49 streptavidin-biotin chemistry to functionalize inorganic nanoparticles with single stranded DNA. 50 We then mixed DNA-functionalized nanoparticles together with linker DNA strands containing 51 complementary sequences to initiate their assembly into colloidal superstructures. The 52 architecture of the assembled superstructure was controlled by using both nanoparticle geometry 53 and DNA grafting density, the latter determined the number of connections each nanoparticle 54 makes with other building blocks. Finally, the outer surface of the resulting superstructure was 55 coated with additional ligands to present the appropriate surface chemistries for interfacing with 56 biological systems. This was achieved by assembling nanoparticles with low DNA grafting 57 densities on the outer layer of the superstructure, such that their unsaturated surfaces provide 58 binding sites for ligand attachment. 59 Here, we used a "core-satellite" architecture to build DNA-assembled superstructures 60 where one or multiple layers of satellite nanoparticles surround a central core nanoparticle 23,24 61 ( Fig.1b) . Each layer of the core-satellite was encoded by a unique DNA sequence, such that 62 nanoparticles grafted with the specific DNA sequence inserted into the corresponding layer. A 63 linker DNA containing complementary regions to every layer joined the nanoparticles together. 64 Each layer of nanoparticles can be designed with a different composition, size, or surface 65 chemistry (Fig.1b) . This modularity allowed us to construct superstructures with controlled 66 dimensions and multiple functionalities from relatively simple building blocks. The permutations 67 amongst nanoparticle designs and DNA sequences can also quickly generate superstructures with 68 distinct physiochemical properties. Figure 1c shows the use of 2 unique nanoparticle building 69 blocks and 2 DNA sequences (e.g. 2 layers) to give 2 2 =4 unique core-satellite superstructures. The 70 total number of unique superstructures increases exponentially with increasing number of core-71 satellite layers and nanoparticle designs. For example, the combination of 10 nanoparticle designs 72 in a 3-layer (e.g. 3 DNA sequences) core-satellite would give 3 10 = 59049 unique superstructures; 73 the use of "n-layer" core-satellites with m nanoparticle designs gives n m unique superstructures, 74 each may interact differently with cells and tissues. This diversity of superstructure candidates 75 will allow us to identify designs with high biological stability, low non-specific biological 76 interactions, and favourable pharmacokinetics for disease targeting. 77 Based on these principles, we generated a sub-library of colloidal superstructures with 78 different hydrodynamic sizes and surface chemistries to study the impact of their design on 79 molecular and cellular interactions. Figure 2a-c shows the simplest 2-layer core-satellite 80 structures that were synthesized for these experiments. First, we synthesized 13nm gold 81 nanoparticles and used them as the core by grafting them with thiolated core oligonucleotides at a 82 density of ~0.12DNA/nm 2 . This density corresponded to a valency of 80 to 90 DNA strands per 83 particle, allowing them to make a large number of connections with the satellites. DNA grafting 84 density was controlled by varying the DNA-to-nanoparticle grafting stoichiometry and quantified 85 by using a fluorescence depletion assay (Supplementary Fig.1 ). We then synthesized 3 and 5nm 86 gold nanoparticles as the satellites by coating them with the satellite oligonucleotide sequence at a 87 density of ~0.05 DNA/nm 2 . This density corresponded to 2 to 3 DNA strands per particle, which 88 was sufficient to stabilize the satellites against aggregation but minimized their probability of 89 cross-linking superstructures into macroscopic aggregates. We note that this low DNA coverage 90 also left the rest of the satellite nanoparticle surface available for further ligand conjugation. A 91 linker DNA containing complementary regions to both the core and satellite sequences was used to 92 join these nanoparticles together. To assemble core-satellites, we first annealed a stoichiometric 93 amount of linker DNAs with the core nanoparticles in a hybridization buffer that was first heated 94 to 60 o C for 10 minutes and then kept at 37 o C for 2 hours. Linker-hybridized core nanoparticles 95 were then purified by centrifugation and subsequently combined with satellite nanoparticles 96 under similar hybridization conditions. We used a 100X molar excess of satellite nanoparticles per 97 core nanoparticle to further eliminate the probability of superstructure cross-linking. Following 98 core-satellite assembly, colloidal superstructures were back-filled with the polymer poly(ethylene 99 glycol) (PEG) to improve their biological stability and reduce non-specific interactions with 100 biomolecules and cells 25 . We used 4 different linker stoichiometries (2, 8, 16 , 24 linkers per core, 101 see characterization in Supplementary Fig.2) , which generated superstructures with different 102 satellite-to-core ratios ( Fig.2A ). We used 3 different lengths of PEG (1, 5, 10kDa) to control overall 103 superstructure surface chemistry and morphology ( Fig.2b ). We also generated 3-layer core-104 satellite structures in which a third DNA sequence (satellite2) hybridizes to an internal region of 105 the linker (see schematic in Supplementary Fig.3 and images in Fig.2c-i) . By grafting this DNA 106 sequence onto other sets of nanoparticles, superstructures with additional satellite layers could be 107 constructed ( Fig.2c ii-iv and Supplementary Fig.4 ). Varying these parameters generated a Supplementary Fig.6 ) demonstrated that these superstructures were monodisperse and 111 colloidally stable in saline.
112
A key question regarding the biological application of colloidal superstructures is whether 113 they can carry and protect pharmaceuticals against biological degradation. We found that 114 therapeutic or imaging agents such as doxorubicin and several fluorescent molecules can be 115 incorporated into superstructures through DNA intercalation or groove binding ( Fig.2e ).
116
Incorporation efficiency was dependent on linker sequence, improving with increasing number of 117 TCG repeats which is a known binding site for doxorubicin 26 . Other agents such as quantum dots 118 and fluorescein amidite (FAM), which do not intercalate or bind DNA directly, could be 119 incorporated within superstructures as hybridized DNA conjugates ( Fig.2f ). An advantage of using 120 assembly to store these agents is that they are embedded within the superstructure and not 121 exposed on the nanoparticle surface ( Fig.2g ). By selecting the appropriate core and satellite 122 building blocks, superstructures enhanced DNA resistance against nuclease and serum 123 degradation by up to 5-fold relative to non-assembled nanoparticles (Supplementary Fig.7 ). This 124 improvement in DNA stability effectively protected the superstructures and its payloads from 125 disintegrating in biological solutions. These results provide the first example of using assembly 126 architecture to mediate payload stability, and highlight a novel strategy to build integrated 127 platforms that carry multiple functionalities. The potential application of colloidal superstructures as delivery platforms motivated us to 131 further investigate their interactions with cells. We selected J774A.1 murine macrophages as a 132 model cell system because macrophages sequester the majority of in vivo administered 133 nanoparticles 27 . Sequestration of nanoparticles by macrophages not only limits the dose that is 134 available to accumulate at diseased sites but is further associated with immune-toxicity 28,29 . The 135 ability to control nanoparticle interactions with macrophages could improve disease-specific 136 delivery and reduce toxicity. We measured macrophage uptake by incubating J774A.1 cells in 137 culture media containing gold nanoparticles for 4 hours and then analysing the total cellular gold 138 content using inductively coupled plasma atomic emission spectroscopy (ICP-AES, Fig.3a ). To 139 assess the impact of nanoparticle design and assembly on uptake, we first exposed macrophages 140 separately with 13nm core nanoparticles, 5nm satellite nanoparticles coated with 1kDa PEG, as 141 well as superstructures assembled using these two components. Figure 3b shows that 142 macrophages sequestered 13nm core nanoparticles 7 times more effectively than 5nm satellite 143 nanoparticles coated with PEG 1kDa, consistent with previous findings that macrophage uptake 144 correlates with nanomaterial size and surface charge 30 . Interestingly, the core-satellite 145 superstructure was 2.5 times larger than its core component but resulted in 2-fold lower uptake 146 into macrophages, suggesting that the superstructure displayed a different surface chemistry 147 which inhibited its uptake. These results also motivated us to systematically characterize the 148 impact of building block design and their assembly architecture on macrophage uptake. We used 149 serum-free culture media for these experiments because our results (Supplementary Fig.8 ) and a 150 previous study 31 have shown that DNA coated nanomaterials are taken up by cells through direct 151 interactions with receptors (e.g., scavenger receptors) on the cell surface rather than through 152 interactions with serum proteins adsorbed on the nanomaterial surface. Here we observed a 153 monotonic decrease in superstructure uptake by macrophages as a function of satellite-to-core 154 ratio ( Fig.3c ), suggesting that satellites inhibited macrophages from interacting with the core.
155
This hypothesis is further supported by the different dose-responses between these 156 nanomaterials; macrophages sequestered DNA coated core nanoparticles in a dose-independent 157 manner suggesting that cells take up such nanoparticles efficiently. In contrast, core-satellite 158 structures exhibited a dose-dependent decrease in cell uptake similar to PEGylated nanomaterials 159 ( Supplementary Fig.9 ). The length of PEG on the satellites also impacted macrophage uptake, 160 where an increase from PEG 1 to 10kDa reduced macrophage uptake by an additional 30% 161 ( Fig.3d ). Interestingly, 5nm nanoparticles were ~2 times more effective than 3nm nanoparticles 162 at mitigating core-satellite uptake by macrophages, implying they provide a denser PEG surface 163 chemistry ( Fig.3e ). Taken together, the optimal superstructure design reduced macrophage 164 uptake by 80% relative to the core nanoparticle, despite being 3 times larger in size. This was 165 achieved by using 5nm nanoparticles coated with PEG 10kDa as satellites at a saturating satellite- (Fig.4a ). Electron micrographs reveal that superstructures associated with the extracellular 179 membrane of macrophages both as single entities (Supplementary Fig.11 ) and as clusters 180 ( Fig.4b-i ). Associated superstructures were eventually internalized by macrophages within 181 vesicles, in which superstructures disassembled into their respective building blocks ( Fig.4b-ii ).
182
We did not observe intact superstructures within macrophages, even in cells fixed immediately 183 following exposure to the superstructures (Supplementary Fig.12 ), suggesting that the 184 intracellular degradation of superstructures occurred rapidly. In contrast, superstructures 185 incubated in culture medium alone (i.e. without cells) remained largely intact over 8 hours of 186 incubation ( Fig.4c ), indicating that superstructure degradation was intracellularly-mediated.
187
Phagocytic vesicles are known to contain a complex mixture of 40 or more hydrolytic enzymes 188 that are responsible for digesting foreign pathogens or endogenous debris. It is possible for this 189 mixture to quickly hydrolyse the DNA linkages that connect the nanoparticles together 32, 33 . While 190 many nanoparticle formulations have been reported to aggregate under such environments 6 , 191 superstructure components remained dispersed following breakdown. These building blocks 192 eventually escaped from the vesicles and distributed throughout the cellular cytoplasm ( Fig.4b-193 iii). To test whether this intracellular behaviour is mediated by superstructure assembly, we Supplementary Fig.13-14) . In cells incubated with core nanoparticles, endocytosis resulted in 199 the appearance of nanoparticle clusters that were confined within vesicles and grew in size over These results prompted us to carry out a parallel experiment, in which we measured 209 changes in total intracellular gold content to assess whether dispersed building blocks could 210 escape from these macrophages following uptake (Fig.4d) . In cells treated with superstructures, 211 we found a 10 to 40% reduction in intracellular gold content over the course of 8 hours (Fig.4e ).
212
The extent of this reduction was dependent on satellite design. In contrast, no change in gold 213 content was measurable in cells incubated with core nanoparticles alone ( Fig.4e ), suggesting that 214 measured differences were attributable to the satellites. These differences occurred 215 independently of changes in cell density (Supplementary Fig.15 ) and plasma membrane 216 permeability ( Supplementary Fig.16) , and were apparent when cells harvested from different 217 time points were cross-examined under TEM (Supplementary Fig.17) . Control experiments 218 further verified that satellites alone escaped macrophage sequestration in a time-and PEG length-219 dependent manner ( Fig.4f and Supplementary Fig.18) . While the role of nanoparticle and PEG 220 size in cellular uptake has been widely reported, results herein suggest that these design 221 parameters also define the thresholds for cellular excretion, which has implications for the in vivo 222 clearance and toxicity of nanomaterials. Additionally, molecular assembly techniques may offer a 223 unique approach whereby PEGylated satellite nanoparticles can be used to facilitate therapeutic 224 delivery without contributing significantly to overall in vivo persistence of nanomaterials. and diminished rapidly with nanoparticle size (Fig.5a ). Building on these results we assembled 235 core-satellites with the smallest satellite nanoparticles to test the ability of superstructures to 236 undergo renal clearance. Urinary excretion efficiency of superstructures mirrored closely with the 237 clearance behaviour of their building blocks ( Fig.5b ), suggesting they can be engineered to 238 eliminate from the body unlike larger solid nanoparticles. More importantly, this result 239 underscores an approach to tailor the size and surface chemistry of nanostructures for mediating 240 their delivery while allowing them to clear from the body.
241
Finally, we assessed the potential of using superstructures to target tumours via a passive 242 mechanism. Preliminary results with xenograft tumour models demonstrate that one of our 243 current superstructure formulations accumulated within tumours better than its controls (e.g. 244 core nanoparticle and non-assembled mixture) following systemic administration (Fig.5c ). Using 245 a previously published procedure for fluorescently-labelling gold nanoparticles 34 , we chemically 246 conjugated this formulation with near-infrared dyes in order to monitor their distribution in 247 tumour xenograft models in real time. Our characterization shows the structures were not altered 248 during this modification (Supplementary Fig.19) . Whole-animal fluorescence imaging showed 249 that this superstructure design increased tumour-specific fluorescence contrast steadily over time 250 (Supplementary Fig.20) , achieving a final tumour-over-background ratio of 2.3±0.1 and a signal-251 over-noise ratio of 5.2±0.5 at 24 hours following administration ( Fig.5d and Supplementary 252 Fig.21a-b) . Analysis of the fluorescence images estimated a blood circulation half-life of 5 hours 253 (Supplementary Fig.21c ). To ensure that superstructures were non-toxic, we collected blood 254 from these animals for biochemistry and haematology analysis, and harvested organs for 255 biodistribution and histology analysis. Results show that, while a large proportion of these 256 superstructures also accumulated in the liver and spleen (Supplementary Fig.22) , they did not 257 cause acute toxicity and were well-tolerated by the animals at the given dose (Supplementary 258 Fig.23-24) . Together, these results demonstrate promise of using molecularly assembled 259 superstructures for in vivo biomedical applications. As a next step, we are currently preparing a 260 library of nanoparticles to further investigate and understand the effect of design on the rate and 261 efficiency of tumour accumulation and whole-body clearance, similar to our previous study 9 . Our 262 current findings have now defined the required building block designs and assembly architectures 263 to engineer superstructures that can accumulate in tumours and be eliminated from the body. In summary, we demonstrated the use of molecular assembly to mediate the biological delivery 267 and elimination of nanoparticles. We showed that colloidal superstructures assembled with the Targeting Efficiency of Nanoparticles Through Design. Nano Lett. 9, 1909 Lett. 9, -1915 Lett. 9, (2009 was determined by measuring the amount of gold in the cells (tube 1) relative to the total dose of gold 412 administered (tube 2). b, Relative uptake efficiency of 13nm core nanoparticles, 5nm-PEG1kDa satellite 413 nanoparticles, and their corresponding superstructures by macrophages. c, Macrophage uptake of 414
superstructures as a function of satellite-to-core ratios. d, Macrophage uptake of superstructures with 415
varying PEG lengths (satellite-to-core ratio kept constant at 24). e, Effect of satellite size on superstructure 416 uptake by macrophages. Error bars represent S.E.M. from at least three independent replicates; *P<0.05, 417 **P<0.01, ***P<0.001. 418 
